pamidronatdinatrium "pfizer" 3 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - pamidronsyre, vandfrit - koncentrat til infusionsvæske, opløsning - 3 mg/ml
venlafaxin "pfizer" 150 mg depotkapsler, hårde
pfizer aps - venlafaxinhydrochlorid - depotkapsler, hårde - 150 mg
venlafaxin "pfizer" 37,5 mg depotkapsler, hårde
pfizer aps - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
venlafaxin "pfizer" 75 mg depotkapsler, hårde
pfizer aps - venlafaxinhydrochlorid - depotkapsler, hårde - 75 mg
voriconazol "pfizer" 200 mg filmovertrukne tabletter
pfizer aps - voriconazol - filmovertrukne tabletter - 200 mg
voriconazol "pfizer" 50 mg filmovertrukne tabletter
pfizer aps - voriconazol - filmovertrukne tabletter - 50 mg
voriconazol "pfizer" 200 mg pulver til infusionsvæske, opløsning
pfizer aps - voriconazol - pulver til infusionsvæske, opløsning - 200 mg
voriconazol "pfizer" 40 mg/ml pulver til oral suspension
pfizer aps - voriconazol - pulver til oral suspension - 40 mg/ml
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler til systemisk brug, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler til systemisk brug, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.